In Silico Approach to Finding New Active Compounds from Histone Deacetylase (HDAC) Family

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|23|3488-3497

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.23, 2016-06, pp. : 3488-3497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-07 ,pp. : 841-858

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-01 ,pp. : 919-928

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: New Hope for Rheumatoid Arthritis?

By  

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 803-820

Bentham Science Publishers

Access to resources Recommend Favorite

Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs

By  

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3467-3479

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Histone Deacetylase as New Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 8, Iss. 12, 2001-10 ,pp. : 1505-1511

Bentham Science Publishers

Access to resources Recommend Favorite